1. Ellis RJ, Toperoff W, Vaida F, et al.: Smoked medicinal
cannabis for neuropathic pain in HIV: A randomized, crossover
clinical trial. Neuropsychopharmacology. 2009; 34(3): 672-680.
2. Wilsey B, Marcotte T, Tsodikov A, et al.: A randomized,
placebo-controlled, crossover trial of cannabis cigarettes in neuropathic
pain. J Pain. 2008; 9: 506-521.
3. Corey-Bloom J, Wolfson T, Gamst A, et al.: Short-term
effects of medicinal cannabis on spasticity in multiple sclerosis.
60th Annual Meeting of the American Academy of Neurology,
Chicago, IL, 2008. Available at www.cmcr.ucsd.edu/geninfo/
jcb_aan_poster.pdf. Accessed April 28, 2009.
4. Abrams DI, Jay CA, Shade SB, et al.: Cannabis in painful
HIV-associated sensory neuropathy: A randomized placebocontrolled
trial. Neurology. 2007; 68: 515-521.
5. Abrams DI, Vizoso HP, Shade SB, et al.: Vaporization as a
smokeless cannabis delivery system: A pilot study. Clin
Pharmacol Ther. 2007; 82: 572-578.
6. Haney M, Gunderson EW, Rabkin J, et al.: Dronabinol and
marijuana in HIV-positive marijuana smokers. Caloric intake,
mood, and sleep. J Acquir Immune Defic Syndr. 2007; 45: 545-554.
7. Wallace M, Schulteis G, Atkinson JH, et al.: Dose-dependent
effects of smoked cannabis on capsaicin-induced pain and hyperalgesia
in healthy volunteers. Anesthesiology. 2007; 107: 785-796.
8. Haney M, Rabkin J, Gunderson E, et al.: Dronabinol and
marijuana in HIV(+) marijuana smokers: Acute effects on caloric
intake and mood. Psychopharmacology. 2005; 181: 170-178.
9. Abrams DI, Hilton JF, Leiser RJ, et al.: Short-term effects of
cannabinoids in patients with HIV-1 infection. A randomized,
placebo-controlled clinical trial. Ann Intern Med. 2003; 139:
258-266.
10. Soderpalm AH, Schuster A, de Wit H: Antiemetic efficacy of
smoked marijuana: Subjective and behavioral effects on nausea
induced by syrup of ipecac. Pharmacol Biochem Behav. 2001;
69: 343-350.
11. Abrams D, Leiser R, Shade S, et al.: Short-term effects of
Cannabinoids on HIV-1 viral load. [abstract no. LbPeB7053].
Poster, XIII International AIDS Conference in Durban, South
Africa. July 9-14, 2000; 13: 45.
12. Greenwald MK, Stitzer ML: Antinociceptive, subjective and
behavioral effects of smoked marijuana in humans. Drug
Alcohol Depend. 2000; 59: 261-275.
13. Greenberg HS, Werness SAS, Pugh JE, et al.: Short-term
effects of smoking marijuana on balance in patients with multiple
sclerosis and normal volunteers. Clin Pharmacol Ther. 1994;
55: 324-328.
14. New York Department of Health study, 1990. In Musty RE, Rossi R: Effects of
smoked cannabis and oral9-tetrahydrocannabinol on nausea and emesis after
cancer chemotherapy: A review of state clinical trials. J Cannabis Ther.
2001; 1: 29-56.
15. Research Advisory Panel: Cannabis therapeutic research program.
Report to the California Legislature, 1989. In Musty RE,
Rossi R: Effects of smoked cannabis and oral d9-tetrahydrocannabinol
on nausea and emesis after cancer chemotherapy: A
review of state clinical trials. J Cannabis Ther. 2001; 1: 29-56.
16. Foltin RW, Fischman MW, Byrne MF: Effects of smoked marijuana
on food intake and body weight of humans living in a
residential laboratory. Appetite. 1988; 11: 1-14.
17. Foltin RW, Brady JV, Fischman MW: Behavioral analysis of
marijuana effects on food intake in humans. Pharmacol
Biochem Behav. 1986; 25: 577-582.
18. Behavioral Health Sciences Division: The Lynn Pierson
therapeutic research program. Health and Environment
Department: New Mexico, 1984. In Musty RE, Rossi R: Effects of
smoked cannabis and oral d9-tetrahydrocannabinol on nausea
and emesis after cancer chemotherapy: A review of state clinical
trials. J Cannabis Ther. 2001; 1: 29-56.
19. Behavioral Health Sciences Division: The Lynn Pierson
therapeutic research program. Health and Environment
Department: New Mexico, 1983. In Musty RE, Rossi R: Effects of
smoked cannabis and oral d9-tetrahydrocannabinol on nausea
and emesis after cancer chemotherapy: A review of state clinical
trials. J Cannabis Ther. 2001; 1: 29-56.
20. Board of Pharmacy, State of Tennessee: Annual report:
Evaluation of marijuana and tetrahydrocannabinol in the treatment
of nausea and/or vomiting associated with cancer therapy
unresponsive to conventional anti-emetic therapy: Efficacy and
toxicity, 1983. In Musty RE, Rossi R: Effects of smoked cannabis
and oral d9-tetrahydrocannabinol on nausea and emesis after
cancer chemotherapy: A review of state clinical trials. J
Cannabis Ther. 2001; 1: 29-56.
21. Kutner MH: Evaluation of the use of both marijuana and
THC in cancer patients for the relief of nausea and vomiting
associated with cancer chemotherapy after failure of conventional
anti-emetic therapy: Efficacy and toxicity, as prepared for
the Composite State Board of Medical Examiners, Georgia
Department of Health, by physicians and researchers at Emory
University, Atlanta, 1983. In Musty RE, Rossi R: Effects of
smoked cannabis and oral d9-tetrahydrocannabinol on nausea
and emesis after cancer chemotherapy: A review of state clinical
trials. J Cannabis Ther. 2001; 1: 29-56.
22. Department of Social Oncology, Evaluation Unit, State of
Michigan: Marihuana therapeutic research project, 1982. In
Musty RE, Rossi R: Effects of smoked cannabis and oral d9-
tetrahydrocannabinol on nausea and emesis after cancer
chemotherapy: A review of state clinical trials. J Cannabis Ther
2001; 1: 29-56.
23. Chang AE, Shiling DJ, Stillman RC, et al.: A prospective evaluation
of delta-9 tetrahydrocannabinol as an antiemetic in
patients receiving adriamycin and cytoxan chemotherapy.
Cancer. 1981; 47: 1746-1751.
24. Merritt JC, Crawford WJ, Alexander PC, et al.: Effect of marihuana
on intraocular and blood pressure in glaucoma.
Ophtalmology. 1980; 87: 222-228.
25. Chang AE, Shiling DJ, Stillman RC, et al.: Delta-9-tetrahydrocannabinol
as an antiemetic in cancer patients receiving high
dose methotrexate. Ann Inten Med. 1979; 91: 819-824.
26. Crawford WJ, Merritt JC. Effects of tetrahydrocannabinol on
arterial and intraocular hypertension. Int J Clin Pharmacol
Biopharm. 1979; 17: 191-196.
27. Greenberg I, Kuehnle J, Mendelson JH, et al.: Effects of marijuana
use on body weight and caloric intake in humans.
Psychopharmacology. 1976; 49: 79-84.
28. Tashkin DP, Shapiro BJ, Frank IM: Acute pulmonary physiologic
effects of smoked marijuana and oral A9-tetrahydrocannabinol
in healthy young men. N Engl J Med. 1973; 289: 336-341.
29. Hill SY, Schwin R, Goodwin DW, et al.: Marihuana and pain.
J Pharmacol Exp Ther. 1974; 188: 415-418.
30. Tashkin DP, Shapiro BJ, Frank IM: Acute effects of smoked
marijuana and oral d9-tetrahydrocannabinol on specific airway
conductance in asthmatic subjects. Am Rev Respir Dis. 1974;
109: 420-428.
31. Tashkin DP, Shapiro BJ, Lee YE, et al.: Effects of smoked
marijuana in experimentally induced asthma. Am Rev Respir Dis.
1975; 112: 377-386.
32. Vachon L, Fitzgerald MX, Solliday NH, et al.: Single-dose effect
of marihuana smoke: Bronchial dynamics and respiratory-center
sensitivity in normal subjects. N Engl J Med. 1973; 288: 985-989.
33. Hollister LE: Hunger and appetite after single doses of marihuana,
alcohol, and dextroamphetamine. Clin Pharmacol Ther.
1971; 12: 44-49.